Serial Number 98853814
641

Registration Progress

Application Filed
Nov 14, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Aug 12, 2025 34 days

Basic Information

Serial Number
98853814
Deadline
August 12, 2025
Description
Respond to Non-Final Office Action
Filing Date
November 14, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
641
Status Date
May 12, 2025
Application
Pending
Classes
005 041 042

Rights Holder

Vividion Therapeutics, Inc.

03
Address
5820 Nancy Ridge Drive
San Diego, CA 92121

Ownership History

Vividion Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Legal Representation

Attorney
Joel E. Tragesser

USPTO Deadlines

Next Deadline
34 days remaining
Non-Final Action Mailed
Due Date
August 12, 2025
Extension Available
Until November 12, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

7 events
Date Code Type Description
May 12, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2025 GNRT F NON-FINAL ACTION E-MAILED
May 12, 2025 CNRT R NON-FINAL ACTION WRITTEN
May 9, 2025 DOCK D ASSIGNED TO EXAMINER
May 8, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 14, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of cancer and immune disorders
Class 041
Providing a website featuring blogs and non-downloadable publications in the nature of articles in the fields of cancer, immune disorders, pharmaceuticals, and proteomics; Providing a website featuring non-downloadable publications in the nature of articles in the fields of cancer, immune disorders, pharmaceuticals, and proteomics
Class 042
Providing medical information in the fields of cancer, immune disorders, pharmaceuticals, and proteomics; Providing a web site featuring medical information; Providing a website featuring information in the fields of cancer, immune disorders, pharmaceuticals, and proteomics

Additional Information

Design Mark
The mark consists of a circle comprising within it a large circle fused with an adjacent smaller circle, the larger of the two fused circles comprising a plus sign in its center.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 041 042